AI

Business

Packaging Hurdle for Aquestive's Anaphylm: A Setback or a Manageable Delay for Its Allergy Ambitions?

Aquestive Therapeutics faces a regulatory delay for its sublingual epinephrine film, Anaphylm, after the FDA raised concerns primarily about its packaging and labeling. The company views the issues as solvable and is moving forward with redesigns and new studies, aiming for a 2026 resubmission while advancing parallel filings abroad.

Feb 3, 2026

Business

UnitedHealth's Steep Decline: A Buying Opportunity or a Value Trap?

UnitedHealth Group shares have tumbled nearly 47% over the past year, significantly underperforming the broader market and raising urgent questions about its valuation. While a standard discounted cash flow model suggests the stock is deeply undervalued, investors are weighing the model's optimistic assumptions against mounting regulatory and operational headwinds in the healthcare sector.

Feb 3, 2026

Business

Antero Resources: Undervalued Gem or Value Trap? Analyzing AR's Valuation Amid Share Price Slump

Following its annual results showing $5 billion in revenue, Antero Resources (AR) faces a valuation conundrum as its share price weakens. While long-term returns remain stellar, recent momentum has cooled, raising questions about its fair value in a shifting energy landscape.

Feb 3, 2026

Business

Jim Cramer Doubles Down on Alphabet, Calls It the 'Best Stock in the Business'

CNBC's Jim Cramer has reaffirmed his bullish stance on Alphabet Inc., labeling the tech giant as the premier holding in his portfolio ahead of its earnings report. The endorsement comes as analysts scrutinize the company's performance in search, cloud, and AI.

Feb 3, 2026

Business

Cramer Backs Merck's Diversification Push, Sees Path Beyond Keytruda Reliance

CNBC's Jim Cramer has spotlighted Merck & Co. as a strategic holding, praising the pharmaceutical giant's acquisition-driven strategy to build a more balanced portfolio ahead of its blockbuster drug's patent cliff.

Feb 3, 2026

Business

Markets Edge Higher Ahead of Earnings Wave, Eyes on Washington as Key Jobs Data Delayed

U.S. stock futures ticked up Tuesday as investors braced for a heavy slate of corporate results, while a partial government shutdown forced a delay of January's crucial employment report, adding uncertainty to the economic outlook.

Feb 3, 2026

Georgia's Water Bill Crisis: Homeowners Hit with Mysterious $1,000 Charges as County Rolls Out Smart Meters

Residents in Clayton County, Georgia, are reeling from unexplained water bill spikes reaching nearly $1,000 monthly, despite no evidence of leaks. As officials promote a county-wide smart meter upgrade, homeowners demand answers and refunds for what they call erroneous charges.

Feb 3, 2026

Trump's Fed Pick Faces an Impossible Balancing Act: Independence vs. Allegiance

President Trump's nomination of Kevin Warsh for Federal Reserve Chair places the former governor in a precarious position, tasked with navigating the President's demands for lower rates while maintaining the central bank's credibility.

Feb 3, 2026

Business

U.S. Factory Activity Roars Back, Fueling Debate Over Bitcoin's Next Move

A sharp rebound in the U.S. manufacturing sector to its highest level in over three years is dividing crypto analysts, with some seeing it as a bullish macro tailwind for Bitcoin and others warning it could delay Federal Reserve rate cuts.

Feb 3, 2026

Business

Denim's Vanguard Gathers in New York: Kingpins 2025 Spotlights Innovation Amid Industry Headwinds

The latest Kingpins New York showcase brought together leading denim supply chain players, highlighting cutting-edge sustainable technologies and deeply personal design narratives, even as attendance figures reflected broader market pressures.

Feb 3, 2026

Business

Lufthansa Bets on Fleet Modernization and Enhanced Service to Mark Centennial Year

As it celebrates 100 years, Lufthansa announces a major fleet expansion and comprehensive service upgrades aimed at improving passenger experience and operational efficiency, following recent struggles with punctuality.

Feb 3, 2026

Business

Prediction Markets Fuel Speculative Frenzy: Five Volatile Cryptos in the Spotlight

As prediction markets surge in popularity, their symbiotic relationship with high-volatility cryptocurrencies like Bitcoin, Ethereum, and Dogecoin is creating new speculative dynamics and attracting retail investors.

Feb 3, 2026

Business

Grab Holdings at a Crossroads: Is the Stock's Recent Slump a Buying Opportunity?

As Grab Holdings' share price hovers near $4.41, a significant divergence emerges between valuation models. A discounted cash flow analysis suggests deep undervaluation, while its sky-high P/E ratio signals overvaluation, leaving investors to weigh the tech giant's long-term potential against its current financial metrics.

Feb 3, 2026

Business

Bridgestone Bets Big on Winter and EVs with New Flagship Blizzak IcePeak Tire

Bridgestone unveils its new Blizzak IcePeak winter tire, engineered with proprietary ENLITEN technology and dual severe snow/ice certifications. The launch marks a strategic consolidation of product lines aimed at capturing the growing premium and electric vehicle segments in the U.S. market.

Feb 3, 2026

Business

ASM International's Five-Year Surge: How a Semiconductor Equipment Maker Delivered 26% Annual Returns

Shares of Dutch semiconductor capital equipment leader ASM International have soared over 210% in the past five years, driven by robust earnings growth and strategic positioning in key chipmaking technologies. While recent monthly gains of 28% turn heads, long-term investors have enjoyed a total shareholder return exceeding 220%, underscoring the company's alignment with enduring industry demands.

Feb 3, 2026

Business

Mikron Holding's Earnings Momentum Draws Investor Scrutiny Amid Market Caution

While speculative 'story stocks' dominate headlines, Swiss manufacturing group Mikron Holding (VTX:MIKN) presents a case study in sustained profitability. With EPS growing at 26% annually over three years and significant insider ownership, the firm offers a contrast to loss-making ventures. Yet, flat revenue and EBIT margins prompt questions about its long-term growth trajectory.

Feb 3, 2026

Business

Analysts Boost IBM Outlook After Strong Q4, Citing Cash Flow Strength and Quantum Potential

Following IBM's fourth-quarter results, Bernstein and Stifel have raised their price targets on the tech giant, highlighting robust free cash flow performance and resilience in its valuation despite sector headwinds.

Feb 3, 2026

Business

Salesforce Secures Landmark $5.6 Billion U.S. Army Contract Amid Strong Commercial Momentum

Salesforce lands a decade-long, multi-billion dollar defense contract while its AI-powered Agentforce platform shows explosive growth, reinforcing analyst confidence in the cloud giant's expansion.

Feb 3, 2026

Business

Truist Securities Lifts Jazz Pharma Target to $230 on Promising Cancer Trial Data

Truist Securities has raised its price target on Jazz Pharmaceuticals (JAZZ) to $230, citing 'practice-changing' results from the HERIZON-GEA trial for its drug Zepzelca in gastroesophageal adenocarcinoma. The firm maintains a Buy rating, anticipating strong commercial adoption and potential guideline inclusion.

Feb 3, 2026

Business

Mirum's M&A Playbook: Betting Big on a Diversified Rare Disease Portfolio

Mirum Pharmaceuticals charts a distinct course in the rare disease biotech landscape, leveraging strategic acquisitions to build a broad, sustainable pipeline while navigating a complex regulatory environment.

Feb 3, 2026